Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Abbreviations Author Contributions Conceptualization, I.A
In addition, government initiatives aimed at improving chronic disease management, coupled with increasing investments by pharmaceutical companies, are positioning China as one of the fastest-growing markets for Glucagon-Like Peptide 1 (GLP-1) Agonists globally
The degradation-resistant GLP-2-analog teduglutide has received approval for the treatment of SBS-IF, in which it may decisively reduce patient dependency on parenteral support and improve quality of life
Dubrow also likes it for weight management (aka maintenance) after slimming down on a stronger drug
It may be administered safely for longer periods, as well
doi: 10.3389/fvets.2022.860771 Received 23 January 2022 Accepted 03 March 2022 Published 06 April 2022 Volume 9 - 2022 Edited by Valeria Pasciu, University of Sassari, Italy Reviewed by Ignacio Contreras Sols, University of Sassari, Italy
US$ 24.81
US$ 29.20
US$ 27.02
US$ 24.72
US$ 22.12
